Intra-arterial clot therapy does not lead to higher rate of independent living, researchers determine

Share this article:

Clot-busting devices administered through the artery do not improve victims' chances of living independently after a stroke, according to research published Thursday.

Researchers funded by the National Institute of Neurological Disorders and Stroke (NINDS) undertook a controlled trial with 656 participants. Between 2006-2012, some of the participants received standard drug therapy of intravenous tissue plasminogen activator (tPA). Others received tPA as well as intra-arterial treatment, in which a catheter run through an artery administers tPA directly to large clots in the brain.

Both groups had a similar statistical likelihood of living independently within 90 days of stroke, the researchers found. Of those who received IV tPA alone, 39% were functionally independent within three months. Among the other group, that number was 41%.

The rate of victim disability was similar, even though intra-arterial treatment is 40% more effective than IV tPA at clot removal, the researchers found. However, intra-arterial therapy is also risky, with 16% of study participants experiencing complications.


Share this article:

More in News

Long-term care continues to lead in deal volume and value: PwC report

Long-term care continues to lead in deal volume ...

Long-term care bucked healthcare industry trends with strong merger and acquisition activity in the second quarter of 2014, according to newly released data from professional services firm PricewaterhouseCoopers.

Empowering nurse practitioners could reduce hospitalizations from SNFs, study finds

Granting more authority to nurse practitioners is associated with reduced hospitalization of skilled nursing facility residents, according to recently published findings.

Pioneer ACO drops out of program, despite reductions in skilled nursing utilization

A California healthcare system has become the latest dropout from the Pioneer Accountable Care Organization program, despite reducing skilled nursing facility utilization and improving its readmission rates. Sharp HealthCare announced its decision in a quarterly financial statement released Tuesday.